Researchers

HAYASHI Hidetoshi

Faculty	Department of Medicine / Graduate School of Medical Sciences
Researchmap	https://researchmap.jp/hayashi_h

Apr. 2023 - Today , Kindai University, Faculty of Medicine Department of Medical Oncology Professor
Apr. 2022 - Today , Kindai University, Faculty of Medicine Department of Medical Oncology 特命准教授
Apr. 2020 - Mar. 2022 , 近畿大学医学部内科学腫瘍内科講師
Oct. 2015 - Mar. 2020 , Kindai university hospital Department of Medical Oncology Lecturer
Apr. 2015 - Sep. 2015 , Kindai university hospital Department of Medical Oncology Assistant professor
Apr. 2013 - Mar. 2015 , Kishiwada City Hospital Department of Medical Oncology Director
Apr. 2009 - Mar. 2013 , Kindai university hospital Department of Medical Oncology assistant professor
Apr. 2006 - Mar. 2009 , Kurashiki Central Hospital Respiratory Medicine Medical Staff
Apr. 2003 - Mar. 2006 , Sumitomo Hospital General Medicine Resident

Cancer of Unknown Primary, Lung Cancer, Gene analysis, medical oncology, immune checkpoint inhibitor

Is EGFR back? ADCs revive targeted therapy in nasopharyngeal carcinoma
Hiroaki Kanemura; Hidetoshi Hayashi
Med Apr. 2026
Analysis of Peripheral T Cell Profiling and Plasma Proteomics in Advanced NSCLC Patients Treated With Atezolizumab
Atsuto Mouri; Hiroshi Kagamu; Koji Tamada; Makoto Nishio; Hiroaki Akamatsu; Yasushi Goto; Hidetoshi Hayashi; Satoru Miura; Akihiko Gemma; Ichiro Yoshino; Toshihiro Misumi; Ryota Saito; Noriko Yanagitani; Fujita Masaki; Hiroshi Nokihara; Kazumi Nishino; Masahiro Seike; Tetsunari Hase; Osamu Hataji; Hiroaki Takeoka; Yosuke Kawashima; Hirotaka Kuroki; Masamichi Sugimoto; Hiroshi Kuriki; Tetsuya Mitsudomi
Cancer Science Apr. 2026
Recovery from fulminant immune-related myocarditis induced by ipilimumab plus nivolumab in malignant pleural mesothelioma: a case report.
Yuki Konya; Junko Tanizaki; Kyohei Onishi; Hiroki Matsuzoe; Hiroaki Kanemura; Takayuki Takahama; Kaoru Tanaka; Gaku Nakazawa; Hidetoshi Hayashi
BMC pulmonary medicine 10, Mar. 2026

Prognostic impact of EMT-related genes on post-operative prognosis in hepatocellular carcinoma. , 永井知行; 荒尾徳三; 松本和子; 藤田至彦; 林秀敏; 木村英晴; 萩原智; 櫻井俊治; 上嶋一臣; 土師誠二; 工藤正俊; 西尾和人 , AACR 103rd Annual Meeting 2011 , Mar. 2012
進行肺腺癌を対象としたゲフィチニブ／S-1併用療法第１層臨床試験 , 清田秀美; 岡本勇; 田中薫; 林秀敏; 寺嶋応顕; 東公一; 武田真幸; 米阪仁雄; 藤阪保仁; 鶴谷純司; 宮﨑昌樹; 佐藤太郎; 倉田宝保; 中川和彦 , 第51回日本肺癌学会総会 , Nov. 2010
進行肺腺癌を対象としたゲフェチニブ／S-1 併用療法第１相臨床試験 , 清田秀美; 岡本勇; 谷﨑潤子; 文田壮一; 岡本邦男; 牧村ちひろ; 竹澤健; 田中薫; 林秀敏; 岡本渉; 寺嶋応顕; 東公一; 金田裕靖; 武田真幸; 上田眞也; 米阪仁雄; 藤阪保仁; 鶴谷純司; 宮﨑昌樹; 佐藤太郎; 倉田宝保; 中川和彦 , 第92回日本肺癌学会関西支部会 , Jul. 2010

Chromosomal instability leads to EGFR-TKI refractoriness via cGAS-STING activation in EGFR-mutated non-small cell lung cancer , Kimio Yonesaka; Takashi Kurosaki; Junko Tanizaki; Hisato Kawakami; Kaoru Tanaka; Osamu Maenishi; Shiki Takamura; Kazuko Sakai; Yasutaka Chiba; Takeshi Teramura; Hiroki Goto; Eri Otsuka; Hiroaki Okida; Masanori Funabashi; Yuuri Hashimoto; Kenji Hirotani; Yasuki Kamai; Takashi Kagari; Kazuto Nishio; Kazuhiro Kakimi; Hidetoshi Hayashi , CANCER RESEARCH , 85 , 8 , 15, Apr. 2025
長期生存を得た切除不能食道癌患者における治療後に生じた他臓器癌の検討 , 渡部亮太郎; 三谷誠一郎; 大倉將生; 稲垣千晶; 谷崎潤子; 田中薫; 岩朝勤; 米阪仁雄; 林秀敏 , 日本内科学会雑誌 , 114 , 2025
A prospective biomarker study of durvalumab after dCCRT in patients with unresectable stage III NSCLC (WJOG11518L) , 豆鞘伸昭; 原谷浩司; 山口哲平; 関根朗雅; 三浦理; 岩永健太郎; 山口正史; 西川和男; 水柿秀紀; 工藤慶太; 中村靖司; 坂井和子; 冨田秀太; 千葉康敬; 伊藤彰彦; 西尾和人; 山本信之; 中川和彦; 林秀敏 , 日本臨床腫瘍学会学術集会(CD-ROM) , 21st , 2024

免疫チェックポイント阻害剤の奏効性の判定を補助する方法、試薬キット、装置及びコンピュータプログラム , 本庶佑, 茶本健司, 林秀敏, 中川和彦, 後藤恵, 宇賀均
免疫チェックポイント阻害剤の奏効性の判定を補助する方法、試薬キット、装置及びコンピュータプログラム , 本庶佑, 茶本健司, 林秀敏, 中川和彦, 後藤恵, 宇賀均 , 特許第7251738号

Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Validation study of a model for estimating the primary organ of cancer of unknown primary by methylation analysis of circulating tumor DNA , Kindai University
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Validation study of a model to estimate the primary organ of cancer of unknown primary , Kindai University
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Analysis of the risk factors for the development and severity of immune-related adverse events by immune checkpoint inhibitors , Kindai University